Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Warren D Hirst

Showing results (11-20 of 72) with videos related to

Pageof 8
Sort By:
The European Journal of Neuroscience|September 22, 2006
Lack of localization of 5-HT6 receptors on cholinergic neurons: implication of multiple neurotransmitter systems in 5-HT6 receptor-mediated acetylcholine releaseBeatriz Marcos, Francisco J Gil-Bea, Warren D Hirst, et al.
Frontiers in Neuroscience|June 12, 2020
Quantitative Measurements of LRRK2 in Human Cerebrospinal Fluid Demonstrates Increased Levels in G2019S PatientsOmar S Mabrouk, Siwei Chen, Amanda L Edwards, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 6, 2021
Evaluation of Strategies for Measuring Lysosomal Glucocerebrosidase ActivityDaniel Ysselstein, Tiffany J Young, Maria Nguyen, et al.
Human Molecular Genetics|August 8, 2015
Pathogenic LRRK2 mutations, through increased kinase activity, produce enlarged lysosomes with reduced degradative capacity and increase ATP13A2 expressionAnastasia G Henry, Soheil Aghamohammadzadeh, Harry Samaroo, et al.
Brain : a Journal of Neurology|November 25, 2023
Nigrostriatal tau pathology in parkinsonism and Parkinson's diseaseYaping Chu, Warren D Hirst, Howard J Federoff, et al.
Plos One|March 13, 2015
Tool compounds robustly increase turnover of an artificial substrate by glucocerebrosidase in human brain lysatesZdenek Berger, Sarah Perkins, Claude Ambroise, et al.
Molecular Pharmacology|December 4, 2003
Differences in the central nervous system distribution and pharmacology of the mouse 5-hydroxytryptamine-6 receptor compared with rat and human receptors investigated by radioligand binding, site-directed mutagenesis, and molecular modelingWarren D Hirst, Bjarke Abrahamsen, Frank E Blaney, et al.
Scientific Reports|August 30, 2018
Self-report data as a tool for subtype identification in genetically-defined Parkinson's DiseaseAshley R Winslow, Craig L Hyde, Jemma B Wilk, et al.
Journal of Neurochemistry|February 6, 2014
Inhibition of glucosylceramide synthase stimulates autophagy flux in neuronsWei Shen, Anastasia G Henry, Katrina L Paumier, et al.
Brain Communications|March 14, 2022
Evaluation of ABT-888 in the amelioration of α-synuclein fibril-induced neurodegenerationLyndsay Hastings, Arpine Sokratian, Daniel J Apicco, et al.
Pageof 8

Showing results (11-20 of 72) with videos related to

Sort By:
Pageof 8
The European Journal of Neuroscience|September 22, 2006
Lack of localization of 5-HT6 receptors on cholinergic neurons: implication of multiple neurotransmitter systems in 5-HT6 receptor-mediated acetylcholine releaseBeatriz Marcos, Francisco J Gil-Bea, Warren D Hirst, et al.
Frontiers in Neuroscience|June 12, 2020
Quantitative Measurements of LRRK2 in Human Cerebrospinal Fluid Demonstrates Increased Levels in G2019S PatientsOmar S Mabrouk, Siwei Chen, Amanda L Edwards, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 6, 2021
Evaluation of Strategies for Measuring Lysosomal Glucocerebrosidase ActivityDaniel Ysselstein, Tiffany J Young, Maria Nguyen, et al.
Human Molecular Genetics|August 8, 2015
Pathogenic LRRK2 mutations, through increased kinase activity, produce enlarged lysosomes with reduced degradative capacity and increase ATP13A2 expressionAnastasia G Henry, Soheil Aghamohammadzadeh, Harry Samaroo, et al.
Brain : a Journal of Neurology|November 25, 2023
Nigrostriatal tau pathology in parkinsonism and Parkinson's diseaseYaping Chu, Warren D Hirst, Howard J Federoff, et al.
Plos One|March 13, 2015
Tool compounds robustly increase turnover of an artificial substrate by glucocerebrosidase in human brain lysatesZdenek Berger, Sarah Perkins, Claude Ambroise, et al.
Molecular Pharmacology|December 4, 2003
Differences in the central nervous system distribution and pharmacology of the mouse 5-hydroxytryptamine-6 receptor compared with rat and human receptors investigated by radioligand binding, site-directed mutagenesis, and molecular modelingWarren D Hirst, Bjarke Abrahamsen, Frank E Blaney, et al.
Scientific Reports|August 30, 2018
Self-report data as a tool for subtype identification in genetically-defined Parkinson's DiseaseAshley R Winslow, Craig L Hyde, Jemma B Wilk, et al.
Journal of Neurochemistry|February 6, 2014
Inhibition of glucosylceramide synthase stimulates autophagy flux in neuronsWei Shen, Anastasia G Henry, Katrina L Paumier, et al.
Brain Communications|March 14, 2022
Evaluation of ABT-888 in the amelioration of α-synuclein fibril-induced neurodegenerationLyndsay Hastings, Arpine Sokratian, Daniel J Apicco, et al.
Pageof 8